Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers
Authors:
- C.E. Hoei-HansenCHC.E. Hoei-Hansen
- E. CarlsenECE. Carlsen
- N. JorgensenNJN. Jorgensen
Open Access
- 18 August 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 22 (1) , 167-173
Abstract
BACKGROUND: Testicular germ cell tumours (TGCTs) originate from a common precursor, carcinoma in situ (CIS). Diagnosis at the CIS stage is desirable as it minimizes the necessary treatment. A detailed clinical evaluation of an approach to detect CIS cells in the ejaculate using primordial germ cell/gonocyte markers is presented. METHODS: Immunocytological staining for AP-2γ [and in some cases, OCT-3/4, NANOG or placental alkaline phosphatase (PLAP)] was performed in semen samples from 294 infertile patients and 209 patients with TGCTs or other diseases. RESULTS: Presence of AP-2γ-stained cells was detected in 50% of participants with CIS and in 33.9% of TGCT patients before treatment (non-seminomas: 56.6%, seminomas: 17.4%). OCT-3/4 results were similar to those of AP-2γ, whereas NANOG and PLAP stainings were unsuitable. Sensitivity was 54.5% for participants harbouring pre-invasive CIS but reduced in participants with overt TGCTs, perhaps because of obstruction. Assay specificity was 93.6%, positive predictive value (PPV) 83.3% and negative predictive value (NPV) 60.3%. CONCLUSIONS: Immunocytological semen analysis based on expression of fetal germ cell markers in exfoliated cells has auxiliary diagnostic value, as it detects some patients with CIS/incipient tumour, but a negative result does not exclude TGCT. Further effort is needed to improve this assay, for example, by employing a more sensitive biochemical method of detection.Keywords
This publication has 27 references indexed in Scilit:
- Paternity Following Treatment for Testicular CancerJNCI: Journal of the National Cancer Institute, 2005
- Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical reviewAnnals of Oncology, 2005
- A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2γ in semen samples: Case reportHuman Reproduction, 2005
- Transcription Factor AP-2γ Is a Developmentally Regulated Marker of Testicular CarcinomaIn situand Germ Cell TumorsClinical Cancer Research, 2004
- Embryonic Stem Cell-Like Features of Testicular Carcinomain SituRevealed by Genome-Wide Gene Expression ProfilingCancer Research, 2004
- Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancerThe Journal of Pathology, 2003
- A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testisAPMIS, 1988
- Carcinoma in situ of the testis: aneuploid cells in semenBMJ, 1988
- CARCINOMA-IN-SITU GERM-CELLS EXFOLIATED FROM SEMINIFEROUS EPITHELIUM INTO SEMINAL FLUIDThe Lancet, 1988
- Detection of Testicular Neoplasms by Cytological Examination of Seminal FluidJournal of Urology, 1987